NAPSA and ovarian cancer: A panel combining three markers: IMP3, Napsin A, and HNF-1β, achieves high diagnostic accuracy (AUC = 0.954), with both sensitivity and specificity above 80% for distinguishing CCOC from other ovarian cancer subtypes and benign conditions [57].